Combretastatin
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Combretastatin, covering 2011-10-31 to 2014-06-09. Get the full timeline:
Most recent: Clinical Trial Update: Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer [Phase 2, Phase 3]